| [1] |
Ley RE,Turnbaugh PJ,klein S, et al. Microbial ecology: human gut microbes associated with obesity[J]. Nature, 2006, 21444(12):1022-1023.
|
| [2] |
Hu Xu,Wang Tao,Jin Feng. Alzheimers disease and gut microbiota[J]. Science China Life Sciences, 2016, 59(10):1006-1023.
|
| [3] |
Mishra AK,Dubey V,Ghosh AR. Obesity: An overview of possible role(s) of gut hormones, lipid sensing and gut microbiota[J]. Metabolism, 2016, 65(1):48-65.
|
| [4] |
Devaraj S,Hemarajata P,Versalovic J. The human gut microbiome and body metabolism: implications for obesity and diabetes[J]. Clinical Chemistry, 2013, 59(4):617-628.
|
| [5] |
Louis S,Tappu RM,Damms-Machado A, et al. Characterization of the gut microbial community of obese patients following a weight-loss intervention using whole metagenome shothun sequencing[J]. PLoS One, 2016, 11(2):e0149564.
|
| [6] |
Turnbaugh PJ,Ley RE,Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest[J].Nature, 2006, 444(7122):1027-1031.
|
| [7] |
Duca FA,Sakar Y,Covasa M, et al. Replication of obesity and associated singaling pathways through transfer of microbiota from obese-prone rats[J]. Diaetes, 2014, 63(5):1624-1636.
|
| [8] |
Chang CJ,Lin CS,Lu CC, et al. Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota[J]. Nature Communication, 2015, 6(7489): 1.
|
| [9] |
Vrieze A,Van Nood E,Holleman F,et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome[J]. Gastroenterology, 2012, 143(4):913-916.e7.
|
| [10] |
Koeth RA,Wang Z,Levison, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis[J]. Nature Medicine, 2013, 19:576-585.
|
| [11] |
Warrier M,Shih DM,Burrows AC, et al. The TMAO-generating enzyme flavin monooxygenase 3 is a central regulator of cholesterol balance[J]. Cell Reports, 2015, 10:326-338.
|
| [12] |
Backhed F,Ding H,Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage[J]. PNAS, 2004, 101(44): 15718.
|
| [13] |
Xu H,Barnes GT,Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance[J]. Journal of Clinical Investigation, 2003, 112(12): 1821-1830.
|
| [14] |
Aron-Wisnewsky J,Gaborit B,Dutour A, et al. Gut microbiota and non-alcoholic fatty liver disease: new insights[J]. Clinical Microbiology and Infection, 2013, 19(4): 338-348.
|
| [15] |
Janero DR,Lindsley L,Vemuri VK, et al. Cannabinoid 1G Protein-coupled receptor (periphero-) neutral antagonists: emerging therapeutics for treating obesity-driven metabolic diease and reducing cardiovascular risk[J]. Expert Opinion on Drug Discovery, 2011, 6(10): 995-1025.
|
| [16] |
Trillou CR,Delgorge C,Menet C, et al. CBI cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced onesity and enhanced leptin sensitivity[J]. Int J Obes(Lond), 2004, 28(4):640-648.
|
| [17] |
Cani PD,Delzenne NM. The role of the gut microbiota in energy metabolism and metabolic disease[J]. Current Pharmaceutical Design, 2009, 15(13):1546-1558.
|
| [18] |
Larsen N,Vogensen FK,Van den Berg FW, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults[J]. PLoS One, 2010, 5(2):e9085.
|
| [19] |
Zhang Xiuying,Shen Dongyuan,Fang Zhiwei, et al. Human gut microbiota changes reveal the progression of glucose intolerance[J]. PLoS One, 2013, 8(8):e71108.
|
| [20] |
Hartstra AV,Bouter KE,Nieuwdorp M, et al. Insights into the role of the microbiome in obesity and type 2 diabetes[J]. Diabetes Care, 2015, 38(1):159-165.
|
| [21] |
Qin Junjie,Li Yingrui,Wang Jun. A metagenome-wide association study of gut microbiota in tape 2 diabetes[J]. Nature, 2012, 490(7418):55-60.
|
| [22] |
Forslund K,Hildebrand F,Nielsen T, et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota[J]. Nature, 2015, 528(7581):262.
|
| [23] |
Sato J,Kanazawa A,Ikeda F, et al. Gut dysbiosis and etection of "Live Gut Bacteria" in biood of Japanese patients with type 2 diabetes[J]. Diabetes Care, 2014, 37(8):2343-2350.
|
| [24] |
Hill JH,Franzosa EA,Huttenhower C,Guillemin K. A conserved bacterial protein induces pancreatic beta cell expansion during zebrafish development[J]. Elife, 2016, 13:5.
|
| [25] |
Batterham RL,Cowley MA,Small CJ, et al. Gut hormone PYY(3-36) physiologically inhibits food intake[J]. Nature, 2002, 418(6898):650-654.
|
| [26] |
Nadkarni P,Chepurny OG,Holz GG. Regulation of glucose homeostasis by GLP1[J]. Progress in Molecular Biology & Translational, 2014, 121:23-65.
|
| [27] |
Lin HV,Frassetto A,Kowalik EJ Jr, et al. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms[J]. PLoS One, 2012, 7(4):e35240.
|
| [28] |
Cani PD,Amar J,Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance[J]. Diabetes, 2007, 56(7):1761-1772.
|
| [29] |
Caricilli AM,Picardi PK,de Abreu LL, et al. Gut microbiota Is a key modulator of insulin resistance in TLR 2 knockout mice[J]. PLoS Biology, 2011, 9(12):e1001212.
|
| [30] |
Li Fei,Jiang Changtao,Krausz KW, et al. Microbiome remodeling leads to inhibition of intestinal farnesoid X receptor signaling and decreased obesity[J]. Nature Communication, 2013, 4:2384.
|
| [31] |
Stenman LK,Holma R,Korpela R. High-fat-induced intestinal permeability dysfunction associated with altered fecal bile acids[J]. World J Gastroenterol, 2012, 18(9):923-929.
|
| [32] |
Yang T,Santisteban MM,Rodriguez V, et al. Gut dysbiosis is linked to hypertension[J]. Hypertension, 2015, 65(6):1331-1340.
|
| [33] |
Nutting CW,Islam S,Daugirdas JT. Vasorelaxant effect of short chain fatty acid salts in rat caudal artery[J]. American Journal of Physiology, 1991, 261:H561-567.
|
| [34] |
Holmes E,Loo RL,Stamler J, et al. Human metabolic phenotype diversity and its association with diet and blood pressure[J]. Nature, 2008, 453:396-400.
|
| [35] |
Gomez-Guzman M,Toral M,Romero M, et al. Antihypertensive effects of probiotics Lactobacillus strains in spontaneously hypertensive rats[J]. Molecular Nutrition & Food Research, 2015, 59(11):2326-2336.
|
| [36] |
Forythe P,Kunze W,Bienenstock J. Moody microbes or fecal phrenology: what do we know about the microbiota-gut-brain axis[J]. BMC Medicine, 2016, 14(1):58.
|
| [37] |
Angelakis E,Armougom F,Million M, et al. The relationship between gut microbiota and weight gain in human[J]. Future Microbiol, 2012, 7(1):91-109.
|
| [38] |
Manzanares W,Lemieux M,Langlois PL, et al. Probiotic and symbiotic therapy incritical illness[J]. Critical Care, 2016, 20(1):262.
|
| [39] |
Everard A,Lazarevic V,Derrien M, et al. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice[J]. Diabetes, 2011, 60(11):2775-2786.
|
| [40] |
Bakken JS,Borody T,Brandt LJ, et al. Treating Clostridium difficile infection with fectal microbiota transplantion[J]. Clin Gastroenterol Hepatol, 2011, 9(12):1044-1049.
|
| [41] |
Young VB. Treatment with fecal microbiota transplantation: the need for complete methodological reporting for clinical trials[J]. Annals of Internal Medicine, 2017.doi: 10.7326/M17-1157. |
| [42] |
Khoruts A,Weingarden AR. Emergence of fecal microbiota transplantation as an approach to repair disrupted microbial gut ecology[J].Immunology Letters, 2014, 162(2 Pt A):77-81.
|
| [43] |
Woodard GA,Encarnacion B,Downey JR, et al. Probiotics improve outcomes after Roux-en-Y gastric bypass surgery: a prospective randomized trial[J]. Journal of Gastrointestinal Surgery, 2009, 13(7):1198-1204.
|
| [44] |
Liou AP,Paziuk M,Luevano JM, et al. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity[J]. Science Translational Medicine, 2013, 5(178):178ra41.
|